Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:JNJ
Johnson & Johnson
|
146.82 | 0% | 0% | 356,431.01 | 3.34% | 3.91% |
|
NYSE:MRK
Merck
|
130.72 | -7.08% | 6.52% | 321,694.58 | 2.43% | -19.03% |
|
LSE:AZN
AstraZeneca PLC
|
120.26 | 19.74% | 42.63% | 186,430.79 | 2.2% | 15.98% |
|
SWX:NOVN
Novartis
|
90.00 | 13.6% | 27.68% | 181,473.74 | 3.7% | 4.67% |
|
SWX:ROG
Roche Holding
|
218.80 | 33.78% | 50.08% | 178,763.82 | 4.32% | 0.43% |
|
NYSE:ABT
Abbott Laboratories
|
106.86 | -0.62% | 11.74% | 186,150.57 | 2.06% | 9.04% |
|
NYSE:PFE
Pfizer
|
25.26 | 19.53% | 52.98% | 147,226.07 | 6.4% | -9.31% |
|
NasdaqGS:AMGN
Amgen
|
269.38 | 1.95% | 12.18% | 144,247.48 | 3.3% | 5.31% |
|
ENXTPA:SAN
Sanofi
|
91.62 | 21.11% | 40.45% | 109,506.23 | 4.29% | 8.19% |
|
NYSE:BSX
Boston Scientific
|
73.26 | -17.21% | -6.76% | 107,170.07 | 0% | 6.88% |
|
NYSE:MDT
Medtronic
|
79.25 | 27.19% | 37.68% | 105,535.34 | 3.43% | 2.09% |
|
NYSE:BMY
Bristol-Myers Squibb
|
44.70 | 59.34% | 69.53% | 90,596.11 | 4.91% | 13.54% |
|
ASX:CSL
CSL
|
278.45 | 27.29% | 48.97% | 130,231.78 | 1.31% | 7.18% |
|
NasdaqGS:GILD
Gilead Sciences Inc
|
65.27 | 22.12% | 31.5% | 81,389.69 | 4.59% | 0.15% |
|
LSE:GSK
GSK
|
16.41 | 19.26% | 36.94% | 65,336.14 | 3.55% | 0.4% |
|
NYSE:SHW
Sherwin Williams
|
304.81 | 7.11% | 20.37% | 76,828.69 | 0.94% | 10.86% |
|
TSE:4568
Daiichi Sankyo Company
|
4766.00 | 0% | 0% | 9,606,688.48 | 1.27% | 0% |
|
TSE:4502
Takeda Pharmaceutical Company
|
4090.00 | 0% | 0% | 6,383,951.56 | 4.55% | 0% |
|
NYSE:PPG
PPG Industries
|
129.23 | 37.51% | 53.33% | 30,794.84 | 1.99% | 5.32% |
|
NasdaqGS:BIIB
Biogen
|
202.46 | -3.23% | 13.94% | 29,361.43 | 0% | -10.89% |
